Brief: Pharvaris Reports Fourth Quarter Results, Provides Business Highlights
Brief: Pharvaris NV Files For Mixed Shelf Of Up To $350 Million – SEC Filing
Brief: Pharvaris NV Announces Appointment Of Elisabeth Björk M.D. To The Board Of Directors
Pharvaris NV reports results for the quarter ended in September - Earnings Summary
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV expected to post a loss of 45 cents a share - Earnings Preview
Pharvaris NV reports results for the quarter ended in June - Earnings Summary
Brief: Pharvaris Reports Q2 Loss Per Share Of EUR 0.94
Pharvaris BV reports results for the quarter ended in March - Earnings Summary
Brief: Pharvaris Reports First Quarter 2021 Financial Results And Provides Business Highlights
Pharvaris BV reports results for the quarter ended in December - Earnings Summary
Brief: Pharvaris Reports Full Year 2020 Financial Results And Provides Business Highlights